Study ID: TV50717-CNS-30060 | 2017-002976-24

Study Title

A Study to Test if TEV-50717 is Effective in Relieving Tics Associated With Tourette Syndrome (TS)

Teva Identifier

TV50717-CNS-30060 | 2017-002976-24

ClinicalTrials.gov Identifier

NCT03571256

Study Status

Completed

Trial Condition(s)

Tourette Syndrome

Interventions

Drug: TEV-50717 | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
neurology icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

6 Years to 16 Years

Trial Duration

May 31, 2018 - December 9, 2019

Phase

Phase 3

Additional info

Study Type

Interventional